Zomedica Upcoming TRUFORMA™ on March 30, 2021

AMEX:ZOM   Zomedica Corp
Protected by approximately 70 issued and pending patents, the TRUFORMA diagnostic platform uses Bulk Acoustic Wave (“BAW”) technology, developed by Qorvo (NASDAQ: QRVO ), to provide a non-optical and fluorescence-free detection system for use at the point-of-care.
BAW technology, also used in cell phones and in the world’s most advanced radar and communications systems, is an extremely reliable and precise technology.
Zomedica expects to begin commercial sales of TRUFORMA on March 30, 2021.
Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM ) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians.
Zomedica’s product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. (source:

Please leave me a message if you want to test the buy and sell indicators that i am using.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.